DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

CIK: 1533357 Filed: September 25, 2025 10-K

Key Highlights

  • Signed testing deal with Homeland Security in May 2024 and passed 500+ lab/field tests.
  • Received a positive 36-page federal report validating technology.
  • Converted $773k debt to stock for temporary debt relief.

Financial Analysis

DEFENSE TECHNOLOGIES INTERNATIONAL CORP. Annual Investor Review - 2025

Let’s break down how Defense Tech performed this year – the good, the bad, and the risky.


1. What They Do

They make passive security scanners (using Earth’s magnetic field) to detect weapons in schools, airports, and public buildings. No radiation – a key selling point vs competitors. Pivoted from gold mining in 2017; now operate through subsidiary PSSI (76% owned).

New in 2024: Signed a testing deal with Homeland Security (May 2024) and passed 500+ lab/field tests. Received a positive 36-page federal report.


2. Financial Performance: Troubling Trends

Revenue:

  • $0 this year (down from $49k last year).
  • Sold only 10 scanners total since 2016.

Losses:

  • $942k net loss (up 64% from last year’s $575k loss).
  • Cumulative losses: $18 million over time.

Why the Losses?

  • Operating costs doubled to $1.38M (legal fees, admin bloat).
  • Wrote off $378,600 for a failed tech license.
  • Total debt exceeds assets by $9.1 million (up 17% YoY).

Inventory Quirk:

  • Only $7,599 in parts left (down from supplies for 25 scanners last year).
  • Values old parts at current prices – may hide outdated inventory.

3. Cash & Debt: Red Flags

Cash Crisis:

  • Out of money as of April 2025 – can’t fund operations without new cash.

Debt Problems:

  • Owe $380,770 to suppliers + $11,072 to insiders.
  • Took $387k in emergency loans (July 2024-Feb 2025) with 15-20% upfront fees.
  • $12,500 loan already in default (missed Feb 2025 payment).

Stock Collapse Risk:

  • Issued 10.6 MILLION new shares this year to pay debt/consultants:
    • 850,000 shares given away for $85 total ($0.0001/share).
    • 685,825 shares (worth $34k) used to settle debt.
  • Share price dropped 14% ($0.07 β†’ $0.06) in late 2024.

Auditor Warning: β€œSerious doubt they can stay in business.”


4. Bright Spots (Few But Notable)

  • Tech Validation: Homeland Security testing adds credibility.
  • Debt Relief: Converted $773k debt to stock (but diluted shareholders).

5. Major Risks

  • No Sales Pipeline: Two straight years of near-zero revenue.
  • Cash Burn: Needs funding immediately to avoid shutdown.
  • Beta Test Risk: Texas high school trial ongoing – failure could kill reputation.
  • IRS Audit Exposure: Tax filings back to 2016 could be reviewed.
  • License Dependency: Tech relies on a 2016 agreement – if lost, business ends.

6. Future Outlook

Plan: Secure investor cash, mass-produce scanners, and hope for government contracts.
Reality Check:

  • No visible sales momentum.
  • Surviving on high-fee loans and stock dilution.
  • Assets depreciating quickly (scanners lose value in 3 years).

Key Takeaways for Investors

🚩 Avoid Unless High-Risk Tolerance 🚩

  • Strengths: Innovative tech, federal testing approval.
  • Weaknesses: No revenue, rising debt, cash crisis, shareholder dilution.
  • Critical Risks: Defaulted loans, IRS audits, stock price collapse.

Bottom Line: Defense Tech is a speculative bet. Success hinges on landing a major contract soon. Without it, this stock resembles a sinking ship. Existing investors should watch for dilution; new investors should wait for proof of sales.

Note: The company provided limited details about their sales strategy, which reduces transparency for investors.

Risk Factors

  • Out of cash as of April 2025, requiring immediate funding to avoid shutdown.
  • Two consecutive years of near-zero revenue ($0 in 2025, $49k in 2024).
  • $12,500 loan already in default with missed February 2025 payment.

Financial Metrics

Revenue $0
Net Income -$942k
Growth Rate -100% (revenue decline)

Document Information

Analysis Processed

September 26, 2025 at 08:57 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.